key: cord-1003421-pf52n20k
authors: Obando‐Pereda, Gustavo
title: Can molecular mimicry explain the cytokine storm of SARS‐CoV‐2?: An in silico approach
date: 2021-06-11
journal: J Med Virol
DOI: 10.1002/jmv.27040
sha: 0f80700bca3e2dadfc9eb7614333ec68a0b11614
doc_id: 1003421
cord_uid: pf52n20k

PARP14 and PARP9 play a key role in macrophage immune regulation. SARS‐CoV‐2 is an emerging viral disease that triggers hyper‐inflammation known as a cytokine storm. In this study, using in silico tools, we hypothesize about the immunological phenomena of molecular mimicry between SARS‐CoV‐2 Nsp3 and the human PARP14 and PARP9. The results showed an epitope of SARS‐CoV‐2 Nsp3 protein that contains consensus sequences for both human PARP14 and PARP9 that are antigens for MHC Classes 1 and 2, which can potentially induce an immune response against human PARP14 and PARP9; while its depletion causes a hyper‐inflammatory state in SARS‐CoV‐2 patients.

SARS-COV-2 was described in December 2019 as being the result of zoonotic transmission from wild animals traded in the Wuhan market 1 to humans presenting primarily symptoms such as fever, nonproductive cough, and myalgia or fatigue, normal or decreased leukocyte counts, and radiographic evidence of pneumonia. 2 Syndrome -CoV (SARS-CoV) genome, 3 and researchers changed the initial name to Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2). 4 In a year, by March 21, 2021, 5 this new disease produced a pandemic with 122.524 million cases and over 2.7 million deaths worldwide.

The SARS-CoV-2 is an enveloped positive-sense RNA virus belonging to the Coronaviridae, genus Betacoronavirus 6,7 family. The SARS-CoV-2

genome contains 14 open reading frames (ORFs), 4 encoded structural proteins, spikes (S), a membrane (M), an envelope (E), and a nucleocapsid (N) that constitute a protective shell surrounding the genetic material. 8 Other remaining proteins, such as the NsP1-16 and 9 other accessory proteins enhance its virulence. 8 The nonstructural protein 3 (Nsp3) is an important protein for the virus to process viral polyproteins and build a fully functional complex allowing viral propagation. 9 Another function of the Nsp3 is its significant role in regulating the host's inflammatory and immune response. 1 Several studies demonstrate that the Nsp3 and the human poly-adenosine diphosphate-ribose polymerase 9 (parp9) 10 and parp14 1 have identical residues that could produce molecular mimicry, leading to leukopenia and an altered inflammatory response. 1, 10 This condition can be explained by a cytokine storm state, related to the macrophage activation syndrome (MAS). 11, 12 The PARPs are a family of important enzymes that catalyze posttranslational ribosylation modification of proteins using NAD + as a substrate to carry out mono or poly ADP-ribosylation modification on target proteins to trigger many processes of cellular metabolism, such as DNA repair, 13 regulation of disease pathogenesis, 14 modulation of immune response 1 and is involved in viral infections. 15 Seventeen PARP family members have been described, 16 the most important in immune regulation being PARP14 and PARP9. 13, 17 PARP14 increases IL-4 induced cytokine through STAT6, 14 responsible for anti-inflammatory macrophage activation (M2), 17 immune homeostasis, 1,13 tissue injury and inflammatory macrophage regeneration and regulation (M1). 17 PARP9 as PARP14 is responsible for macrophage activation. 17 In the SARS-COV-2 disease, a molecular mimicry phenomenon has been observed, and two recent studies have reported this phenomenon between viral proteins against PARP9 10 and PARP14. 18 The aim of this study is to analyze the molecular mimicry phenomena using in silico tools between SARS-Cov-2 and human proteins. 

The B-cell epitopes were predicted using the BepiPred server and the Elliprot server to examine the epitope position in a 3D structure. 21 Cytotoxic T lymphocyte (CTL) epitopes were predicted using the IEDB MHC I algorithm (http://tools.iedb.org/mhci) and helper T lymphocyte (HTL) epitopes were predicted using the MHC II binding prediction tools (http://tools.iedb.org/mhcii). The antigenic properties of the epitopes were studied using the Vaxijen 2.0 server at a threshold of 0.4. Peptide toxicity was predicted from the ToxinPred server (http://crdd.osdd.net/ raghava/toxinpred/), and allergenicity was predicted from the AllegernFP 1.0 server (http://ddg-pharmfac.net/AllergenFP/). All of these analyses were taken into account to select the epitopes.

The hydrophobic and antigenic analysis was performed using the Kyte-Doolittle and Jameson-Wolf algorithms of human and viral protein.

To determine whether the epitope found was located on the outer surface of the protein where antigen-antibody formation occurs, an overlay of the predicted epitopes and the results of hydrophobic and antigenic analysis was performed. 22 The DNASTAR Protean program was used for this method.

The three-dimensional modeling of PARP9 was performed using the I-TASSER online server (https://zhanglab.ccmb.med.umich.edu/I-TASSER/), while the Z-score was used to verify the quality of the 3D protein modeling to select the best model. 23 Human PARP14 and Sars-Cov-2 Nsp3 were extracted from PDB (3Q6Z and 6WEY, respectively).

In addition, the 3D structure of the selected epitopes was modeled with the PEPFOLD 3 server. 24 26 The HawKRank server was used for scoring. 27 3 | RESULTS for human PARP14 and PARP9 respectively (Table 1 and Figure 1 ).

The predicted epitope PTVVVNAANVYLKHGGGVAGAL of Nsp3 Figure 2 ). BepiPred showed that the epitopes have a large gradient and that the surface of the structure is exposed ( Table 2 ). As mentioned, the predicted epitope of SARS-CoV-2, for CTL and HTL cells shows predicted epitopes with a high antigenic and allergenic property capable of inducing a large autoimmune response once recognized by the MHC Class I and MHC Class II allele numbers ( Table 2 ).

Hydrophobic and antigenic analyses of SARS-CoV-2 Nsp3 protein and human Parp14/Parp9 for the consensus amino acid sequence are T A B L E 1 Preserved epitopes between SARS-CoV-2 Nsp3 and human Parp9 and Parp14 shown in Table 3 . This data showed that the amino acids of Nsp3, 

SARS-CoV-2 is a new and serious infectious disease that affects the entire world, threatening the health and life of the human population. 28 The infection produced by the virus results in a strong immune response that releases large amounts of cytokines and chemokines, a phenomenon known as cytokine storm, exhibiting systemic hyper-inflammation, leading to a high incidence of immune disorders, organ failure, and mortality. 11, 29, 30 This systemic hyperinflammatory condition is known as MAS that can be associated with SARS-CoV-2 pneumonia and its exacerbation. 11, 12 MAS can occur in severe infections caused by a wide variety of bacterial, fungal, protozoal, rickettsial, and viral pathogens, [31] [32] [33] is also found in patients with severe sepsis with a high risk of mortality. 34 In patients with severe SARS-CoV-2, the MAS profile related to inflammatory macrophage M1 35 which is responsible for the SARS-CoV-2 related macrophage activation syndrome, however, the presence of this cytokine produces the decrease of NK and CD8 + T cells, 28,47 a condition found in patients with severe SARS-CoV-2 infections. 28, 48, 49 This scenario produces in the SARS-CoV-2 patient a state of constant hyper-inflammation, without macrophage immune regulation. The combination of the decrease of PARP14/PARP9 responsible for the polarization of anti-inflammatory macrophages (M2) and a weak host's viral response due to the decrease of NK and CD8 + cells will lead to a fatal outcome for the patient.

The results of this study are in agreement with previous studies denoting the presence of molecular mimicry in SARS-CoV-2 between PARP14/PARP9 and the viral proteome 10, 18 and its importance in the SARS-CoV-2 infection. 50 

Within the limits of this study, it can be assumed that, in patients with severe SARS-CoV-2 infections, a molecular mimicry phenomenon of human PARP14 and PARP9 may be present leading to a hyperinflammatory state due to the macrophage activation syndrome known as cytokine storm-related to SARS-CoV-2.

The author thanks Miguel Chavez Fumagalli for the extensive review of this study. This study is supported by Vicerrectorado de Investigación of Universidad Católica de Santa María, Arequipa, Perú.

A putative role of de-mono-ADP-ribosylation of STAT1 by the SARS-CoV-2 Nsp3 protein in the cytokine storm syndrome of COVID-19

All about COVID-19 in brief

Coronavirus disease 2019: coronaviruses and blood safety

The Lancet Infectious Diseases. Challenges of coronavirus disease 2019

Coronavirus Disease (COVID-2019) Situation Reports

SARS-CoV-2, SARS-CoV, and MERS-COV: a comparative overview

The hallmarks of COVID-19 disease

Proteomics in the COVID-19 battlefield: first semester check-up

SARS-CoV-2-specific virulence factors in COVID-19

Molecular mimicry may explain multi-organ damage in COVID-19

Macrophage activation syndrome and COVID-19

The role of cytokines including Interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease

A study into the ADPribosylome of IFN-gamma-stimulated THP-1 human macrophagelike cells identifies ARTD8/PARP14 and ARTD9/PARP9 ADPribosylation

Research progress on PARP14 as a drug target

The coronavirus macrodomain is required to prevent PARP-mediated inhibition of virus replication and enhancement of IFN expression

Toward a unified nomenclature for mammalian ADPribosyltransferases

PARP9 and PARP14 crossregulate macrophage activation via STAT1 ADP-ribosylation

Sequence homology between human PARP14 and the SARS-CoV-2 ADP ribose 1'-phosphatase

GAKG-RGEKG an epitope that provokes immune cross-reactivity between Prevotella sp. and human collagen: molecular mimicry in chronic periodontitis

Clustal Omega for making accurate alignments of many protein sequences

IEDB-AR: immune epitope database-analysis resource in 2019

Analysis of the genome sequence and prediction of B-Cell epitopes of the envelope protein of Middle East respiratory syndrome-coronavirus

Protein structure and function prediction using I-TASSER

Improved PEP-FOLD approach for peptide and miniprotein structure prediction

DockTope: a webbased tool for automated pMHC-I modelling

Flexible docking of peptides to proteins using CABSdock

HawkRank: a new scoring function for protein-protein docking based on weighted energy terms

COVID-19 pneumonia: CD8(+) T and NK cells are decreased in number but compensatory increased in cytotoxic potential

Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology

Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia

Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol

Secondary hemophagocytic lymphohistiocytosis in zoonoses. A systematic review

Viral infections associated with haemophagocytic syndrome

The genetics of macrophage activation syndrome

Immunometabolic status of COVID-19 cancer patients

Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages

Implications of macrophage polarization in autoimmunity

PARP-14 functions as a transcriptional switch for Stat6-dependent gene activation

PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection

COVID-2019: the role of the Nsp2 and Nsp3 in its pathogenesis

A gapless, unambiguous RNA metagenome-assembled genome sequence of a unique SARS-CoV-2 variant encoding spike S813I and ORF1a A859V substitutions

Role of nonstructural proteins in the pathogenesis of SARS-CoV-2

Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines

Therapeutic potential of B-1a cells in COVID-19

Estimating the binding of Sars-CoV-2 peptides to HLA class I in human subpopulations using artificial neural networks

CD8+ cytotoxic T-APC stimulate central memory CD8+ T cell responses via acquired peptide-MHC class I complexes and CD80 costimulation, and IL-2 secretion

The immunology of macrophage activation syndrome

NK cells: a double edge sword against SARS-CoV-2

COVID-19 and the immune system

The potential association between PARP14 and the SARS-CoV-2 infection (COVID-19)

How to cite this article: Obando-Pereda G. Can molecular mimicry explain the cytokine storm of SARS-CoV-2?: An in silico approach

The authors declare that there are no conflict of interests.

Gustavo Obando-Pereda http://orcid.org/0000-0001-6044-1551